Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells

被引：0

作者：

C Preisinger

J P Schwarz

O B Bleijerveld

E Corradini

P J Müller

K I Anderson

W Kolch

A Scholten

A J R Heck

机构：

[1] Biomolecular Mass Spectrometry and Proteomics Group,Department of Biochemistry

[2] Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences,undefined

[3] Utrecht University,undefined

[4] Netherlands Proteomics Centre,undefined

[5] The Beatson Institute for Cancer Research,undefined

[6] Garscube Estate,undefined

[7] RWTH Aachen University,undefined

[8] Systems Biology Ireland,undefined

[9] University College Dublin,undefined

[10] Belfield,undefined

[11] Centre for Biomedical Genetics,undefined

[12] 7Current address: Proteomics Facility,undefined

[13] Interdisciplinary Centre for Clinical Research (IZKF) Aachen,undefined

[14] RWTH Aachen University,undefined

[15] Aachen,undefined

[16] Germany.,undefined

来源：

Leukemia | 2013年 / 27卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：743 / 746

页数：3

共 50 条

[41] BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features
Neuendorff, Nina Rosa
Burmeister, Thomas
Doerken, Bernd
Westermann, Joerg
ANNALS OF HEMATOLOGY, 2016, 95 (08) : 1211 - 1221
[42] Erratum to: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib
Maël Heiblig
Audrey Bidet
Evelyne Callet-Bauchu
Pierre-Yves Dumas
Kaddour Chabane
Gilles Salles
Arnaud Pigneux
Annals of Hematology, 2017, 96 : 337 - 337
[43] Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL-Positive Cells
Kominsky, Douglas J.
Klawitter, Jelena
Brown, Jaimi L.
Boros, Laszlo G.
Melo, Junia V.
Eckhardt, S. Gail
Serkova, Natalie J.
CLINICAL CANCER RESEARCH, 2009, 15 (10) : 3442 - 3450
[44] Specific inhibition of hTERT by shRNA sensitizes for imatinib mesylate in BCR-ABL-positive cells.
Sashida, G
Tauchi, T
Sumi, M
Nakajima, A
Ohyashiki, JH
Ohyashiki, K
BLOOD, 2004, 104 (11) : 169B - 169B
[45] Dasatinib induces autophagy in mice with Bcr-Abl-positive leukemia
Makiko Morita
Yoko Nishinaka
Itaru Kato
Satoshi Saida
Hidefumi Hiramatsu
Yasuhiko Kamikubo
Toshio Heike
Tatsutoshi Nakahata
Souichi Adachi
International Journal of Hematology, 2017, 105 : 335 - 340
[46] Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemia
Mizuta, Shuichi
Matsuo, Keitaro
Nishiwaki, Satoshi
Imai, Kiyotoshi
Kanamori, Heiwa
Ohashi, Kazuteru
Fukuda, Takahiro
Onishi, Yasushi
Miyamura, Koichi
Takahashi, Satoshi
Onizuka, Makoto
Atsuta, Yoshiko
Suzuki, Ritsuro
Morishima, Yasuo
Kato, Koji
Sakamaki, Hisashi
Tanaka, Junji
BLOOD, 2014, 123 (15) : 2325 - 2332
[47] Diffuse affection of the brain in hypereosinophilic variant of Ph′-negative, BCR-ABL-positive variant of chronic myeloid leukemia.
Khoroshko, ND
Mokeeva, RA
Abakumov, EM
Nemchenko, IS
Semenova, EA
Zakharova, AV
Kobzev, YN
Surin, VL
Dukhovenskaya, EA
Fedorova, SY
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2000, 45 (02): : 30 - 35
[48] Dasatinib induces autophagy in mice with Bcr-Abl-positive leukemia
Morita, Makiko
Nishinaka, Yoko
Kato, Itaru
Saida, Satoshi
Hiramatsu, Hidefumi
Kamikubo, Yasuhiko
Heike, Toshio
Nakahata, Tatsutoshi
Adachi, Souichi
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (03) : 335 - 340
[49] Synergistic activity of nilotinib and established chemotherapeutic agents in imatinib-sensitive and -resistant BCR-ABL-positive leukemia cells.
Radujkovic, Aleksandar
Topaly, Julian
ho, Antny D. Ho
Zeller, W. J.
Fruehauf, Stefan
BLOOD, 2006, 108 (11) : 277B - 278B
[50] Combinational Treatment of Imatinib and Allicin Synergistically Inhibits the Growth of BCR-ABL-Positive Leukemia and the Emergence of Drug-Resistant Cells
Lim, Jamie
Kim, Jung-Hyun
Ahn, Eun-Young Erin
BLOOD, 2017, 130

← 1 2 3 4 5 →